Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Xiuru Ma"'
Autor:
Lifeng Jia, Qi Song, Chenyang Zhou, Xiaoming Li, Lihong Pi, Xiuru Ma, Hui Li, Xiuying Lu, Yupeng Shen
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147157 (2016)
Developing drugs that can effectively block STAT3 activation may serve as one of the most promising strategy for cancer treatment. Currently, there is no putative STAT3 inhibitor that can be safely and effectively used in clinic. In the present study
Externí odkaz:
https://doaj.org/article/fb61d12e3d4a41688cc90b0969a5f3de
Autor:
Yuetao Xie, Xiuru Ma, Mei-Jing Shi, Yi Dang, Yingxiao Li, Qian Yang, Xin-Ning Li, Xuelian Song, Wen-Jing Wang
Publikováno v:
Cardiovascular Toxicology. 21:387-398
This study aimed to investigate the mechanism of how miR-362-3p/orosomucoid 1 (ORM1) involved in hypoxia/reoxygenation (H/R)-induced cardiomyocytes injury. Based on data obtained from Gene Expression Omnibus (GEO) database, we revealed that ORM1 was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c70a5a69f578d2071ba25e2f72c12679
https://doi.org/10.1007/s12012-020-09631-0
https://doi.org/10.1007/s12012-020-09631-0
Autor:
Yi Dang, Xiuru Ma, Qian-Hui Zhang, Yue-Tao Xie, Feifei Zhang, Xiao-Yong Qi, Yingxiao Li, Qingqing Hao
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 106
The protein SET domain-containing lysine methyltransferase 7 (SETD7) has recently been shown to regulate apoptosis in various cells. However, the role of SETD7 on cardiomyocyte apoptosis during myocardial ischemia/reperfusion injury remains unclear.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f08fec1ee8299e7d0521b80af9bb9771
https://pubmed.ncbi.nlm.nih.gov/30119254
https://pubmed.ncbi.nlm.nih.gov/30119254
Autor:
Xi Li, Yan Li, Jintao Xiao, Huiwen Wang, Yan Guo, Xiuru Mao, Pan Shi, Yanliang Hou, Xiaoxun Zhang, Nan Zhao, Minghua Zheng, Yonghong He, Jingjing Ding, Ya Tan, Min Liao, Ling Li, Ying Peng, Xuan Li, Qiong Pan, Qiaoling Xie, Qiao Li, Jianwei Li, Ying Li, Zhe Chen, Yongxiu Huang, David N. Assis, Shi-Ying Cai, James L. Boyer, Xuequan Huang, Can-E Tang, Xiaowei Liu, Shifang Peng, Jin Chai
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
The aetiology of primary biliary cholangitis (PBC) remains unclear. Here, the authors find that the numbers of DUOX2 + ACE2 + small cholangiocytes in human and mouse livers are inversely associated with disease severity, and present data indicating t
Externí odkaz:
https://doaj.org/article/0578e4e9fc164533ad8327d66a6d068c
Publikováno v:
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery. 30(4)
To investigate the effects of combined inhibition of signal transducer and activator of transcription 3 (STAT3) and hypoxia-inducible factor-1α (HIF-1α) in the enhancement of chemosensitivity of the model of human laryngeal squamous cacinoma in nud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32da372c041d066cfeb40d58787b77bf
https://pubmed.ncbi.nlm.nih.gov/27373041
https://pubmed.ncbi.nlm.nih.gov/27373041
Publikováno v:
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery. 21(21)
To investigate the expression of X-chromosome-linked inhibitors of apoptosis (XIAP) XIAP in laryngeal squamous carcinomas and the relationship between the expression of XIAP and clinical biological behaviors.Paraffin-embedded tissue specimens used fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6fab41b4987b0a8c8458f0c4e8ca3d99
https://pubmed.ncbi.nlm.nih.gov/18309651
https://pubmed.ncbi.nlm.nih.gov/18309651
Autor:
Lihong Pi, Xiuying Lu, Qi Song, Lifeng Jia, Yupeng Shen, Chenyang Zhou, Xiaoming Li, Xiuru Ma, Hui Li
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147157 (2016)
PLoS ONE
PLoS ONE
Developing drugs that can effectively block STAT3 activation may serve as one of the most promising strategy for cancer treatment. Currently, there is no putative STAT3 inhibitor that can be safely and effectively used in clinic. In the present study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2766a6eb38a0478b3e46d961ce57c00f
https://doi.org/10.1371/journal.pone.0147157
https://doi.org/10.1371/journal.pone.0147157